CHARLES JONES: Open Payments
NPI 1144319732 · JEFFERSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 19 payments from 11 companies in 2025. Trend: 2023 $158 · 2024 $166 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 3 | $81 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Novo Nordisk Inc | 3 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| ABBVIE INC. | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Viatris Specialty LLC | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: IBSRELA, VOQUEZNA, XIFAXAN, VRAYLAR, Wegovy, TRELEGY ELLIPTA, YUPELRI, REXULTI.
Industry payments across NC — which companies pay providers there.
